If you think you might be able to get your hands on soy milk at a health food store, you’d be wrong.
The US Food and Drug Administration has given a green light to soy products to enter the country for export, according to the Associated Press.
But the FDA is only granting licenses to soy based on their “safety and effectiveness” in clinical trials.
The US Food & Drug Administration is only giving licenses to Soy based on safety and effectiveness in clinical studies.
The FDA is in the process of approving about 60 soy products that have been approved for export.
They are all soy based, which is not a new thing for the FDA.
Soy products have been used in Chinese medicine for thousands of years, and were first approved for human consumption in the 1930s.
The World Health Organization says soy is “essential for human nutrition.”
But the FDA’s approval is the latest in a long line of regulatory hurdles for the industry, which has been fighting to gain import permission in the U.S. since at least 2006.
In 2015, the FDA approved a soy-based milk substitute called Soylent, which can replace regular milk and reduce the amount of calories in the formula.
It’s been available for about six months, but the FDA hasn’t approved Soylend for import yet.
The FDA is currently working on a proposal for an export license that would allow the Soylents to be shipped to countries that require it, including Brazil and Peru, but only if they meet a “high degree of safety.”
That’s not a standard FDA would require.
Soylen, which the FDA has said would have a “similar nutritional profile” to regular milk, has been criticized for the lack of nutrition, as well as the possibility that it could cause health problems.
The Associated Press contributed to this report.